Skip to main content

Yaman Tarabishy, MD

Pathologist

Board Certifications

Anatomic and Clinical Pathology

Fellowship

Gastrointestinal Pathology, Liver Pathology

Locations

ProPath

Biography

ProPath, a Sonic Healthcare anatomic pathology practice, is privileged to include Yaman Tarabishy, M.D., as a part of its dynamic medical staff. Dr. Tarabishy is a board-certified pathologist who brings professional medical and research experience to his position. 

Dr. Tarabishy earned his medical degree from the University of Damascus School of Medicine in Damascus, Syria. He then completed a postdoctoral research fellowship at Mayo Medical School in Rochester, Minnesota. He served a residency in anatomic and clinical pathology at Washington University School of Medicine in St. Louis, Missouri. Following his residency, he completed a fellowship in gastrointestinal and liver pathology at The Johns Hopkins Hospital in Baltimore, Maryland. 

Dr. Tarabishy was a pathologist at Peoria Tazewell Pathology Group in Peoria, Illinois, before joining ProPath.

Dr. Tarabishy has numerous articles published in peer-reviewed journals, including Pathology, American Journal of Surgical Pathology, Cancer, and Gastroenterology Research, among others. He has presented abstracts at a variety of professional conferences, including meetings of the United States and Canadian Academy of Pathology, College of American Pathologists, and the American Society of Clinical Oncology. 

  

Education

University of Damascus School of Medicine (MD)
Damascus, Syria

  

Postgraduate Training

Gastrointestinal and Liver Pathology Fellowship
The Johns Hopkins Hospital
Baltimore, MD

Anatomic and Clinical Pathology Residency
Washington University School of Medicine
St. Louis, MO

  

Professional Memberships

American Society of Clinical Pathology

College of American Pathologists

International Society of Bone and Soft Tissue Pathology

United States and Canadian Academy of Pathology

  

Peer-Reviewed Articles

  1. Dhingra S, Mahadik JD, Tarabishy Y, May SB, Vierling JM. Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis. Pathology. 2022 Oct;54(6):686-693. Epub 2022 May 5.

  2. Yang C, Tarabishy Y, Dassopoulos T, Nalbantoglu Ilk. Clinical, histologic, and immunophenotypic features of serrated polyps in patients with inflammatory bowel disease. Gastroenterol Res. 2018;11(5):355-360.

  3. Salimian KJ, Waters KM, Eze O, Pezhouh MK, Tarabishy Y, Shin EJ, Canto MI, Voltaggio L, Montgomery EA. Definition of Barrett Esophagus in the United States: support for retention of a requirement for goblet cells. Am J Surg Pathol. 2018;42(2):264-268.

  4. Tarabishy Y, Pittman ME. Soft tissue tumors with myxoid stroma: a review of distinguishing clinical and pathological features. AJSP Rev Reports. 2017;22(2):94-101.

  5. Tarabishy Y, Montgomery EA. Vascular tumors of intermediate malignancy and angiosarcoma: a review. AJSP Rev Reports. 2017;22(2):108-115.

  6. Messmer M, Upreti S, Tarabishy Y, Mazumder N, Chowdhury R, Yarchoan M, Holdhoff M. Ipilimumab-induced enteritis without colitis: a new challenge. Case Rep Oncol. 2016;9(3):705-173.

  7. Visscher DW, Frost MH, Hartmann LC, Hartmann LC, Frank RD, Vierkant RA, McCullough AE, Winham SJ, Vachon CM, Ghosh K, Brandt KR, Farrell AM, Tarabishy Y, Hieken TJ, Haddad TC, Kraft RA, Radisky DC, Degnim AC. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Cancer. 2016;122(3):378-385.

  8. Banan B, Chung H, Xiao Z, Tarabishy Y, Jia J, Manning P, Upadhya GA, Mohanakumar T, Lin Y, Chapman WC. Normothermic extracorporeal liver perfusion for donation after cardiac death (DCD) livers. Surg (United States). 2015;158(6):1642-1650.

  9. Lewis JS, Tarabishy Y, Luo J, Mani H, Bishop JA, Leon ME, Prasad ML, Xu H, Di Palma S. Inter- and intra-observer variability in the classification of extracapsular extension in p16 positive oropharyngeal squamous cell carcinoma nodal metastases. Oral Oncol. 2015;51(11):985-990.

  10. Chien J, Sicotte H, Fan JB, Humphray S, Cunningham JM, Kalli KR, Oberg AL, Hart SN, Li Y, Davila JI, Baheti S, Wang C, Dietmann S, Atkinson EJ, Asmann YW, Bell DA, Ota T, Tarabishy Y, Kuang R, Bibikova M, Cheetham RK, Grocock RJ, Swisher EM, Peden J, Bentley D, Kocher JP, Kaufmann SH, Hartmann LC, Shridhar V, Goode EL. TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer. Nucleic Acids Res. 2015;43(14):6945-6958.

  11. Pankratz VS, Degnim AC, Frank RD, Frost MH, Visscher DW, Vierkant RA, Hieken TJ, Ghosh K, Tarabishy Y, Vachon CM, Radisky DC, Hartmann LC. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. 2015;33(8):923-929.

  12. Wahner Hendrickson AE, Hawthorne KM, Goode EL, Kalli KR, Goergen KM, Bakkum-Gamez JN, Cliby WA, Keeney GL, Visscher DW, Tarabishy Y, Oberg AL, Hartmann LC, Maurer MJ. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic. Gynecol Oncol. 2015;137(1):77-85.

  13. Visscher DW, Nassar A, Degnim AC, Frost MH, Vierkant RA, Frank RD, Tarabishy Y, Radisky DC, Hartmann LC. Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat. 2014;144(1):205-212.

  14. Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL, Tarabishy Y, Ghosh K, Visscher DW, Degnim AC. Understanding the premalignant potential of atypical hyperplasia through its natural history: A longitudinal cohort study. Cancer Prev Res. 2014;7(2):211-217.

Abstracts

  1. Tarabishy Y, Karnes H, Koopmeiners A, Dehner L. Concordance between pre- and post-mortem diagnoses in pediatric autopsies. USCAP Meeting, Seattle, WA, 2016.

  2. Tarabishy Y, Nalbantoglu I. Clinical, histologic, and immunophenotypic features of serrated polyps in patients with inflammatory bowel disease.USCAP Meeting, Boston, MA, 2015.

  3. Tarabishy Y, Luo J, Mani H, Bishop J, Leon M, Prasad M, Xu H, Di Palma S, Lewis JS Jr.Interobserver variability in the classification of extracapsular extension in metastatic p16+ oropharyngeal squamous cell carcinoma.CAP ’14 – The Pathologists’ Meeting, Chicago, IL, 2014.

  4. Tarabishy Y, Hartmann LC, Frost MH, Maloney SD, Vierkant RA, Pankratz VS.Performance of the Gail model in individual women with benign breast disease. American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2011.

Previous
Next